Milestone Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Milestone Pharmaceuticals

29/03/2023 15:12

* Milestone Pharmaceuticals Inc  MIST.OQ  reported a
quarterly
adjusted loss of 31 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 33 cents per share.
    * Revenue rose 58% to $3.50 million from a year ago;
analysts
expected $875.00 thousand. 
    * Milestone Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 31 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Milestone Pharmaceuticals Inc shares had risen by 0.8%
this
quarter.
    * The company reported a quarterly loss of $13.18 million.
    * Wall Street's median 12-month price target for Milestone
Pharmaceuticals Inc is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 29 at 02:12 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.33          -0.31          Beat
 Sep. 30 2022      -0.41          -0.34          Beat
 Jun. 30 2022      -0.36          -0.39          Missed
 Mar. 31 2022      -0.39          -0.33          Beat